Novel Peptide DR3penA as a Low-Toxicity Antirenal Fibrosis Agent by Suppressing the TGF-β1/miR-212-5p/Low-Density Lipoprotein Receptor Class a Domain Containing 4/Smad AxisBochuan Deng, Junqiu Xie, Xiang Zhang et al.|ACS Pharmacology & Translational Science|2024Cited by 3